please call me , to know more
*The following content is generated by AI and is for reference only.
<h3>Overview</h3><p>Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist synthesized via solid-phase peptide synthesis. Its molecular formula is C<sub>167</sub>H<sub>265</sub>N<sub>45</sub>O<sub>49</sub> with CAS No. 204656-20-6.</p><h3>Application</h3><ul><li>Pharmaceutical manufacturing for type 2 diabetes management.</li><li>Weight loss therapies in clinical settings.</li><li>R&D of metabolic disorder treatments.</li></ul><h3>Precautions</h3><p>Contraindicated in patients with personal or family history of medullary thyroid carcinoma. Store lyophilized powder at -20°C protected from light to maintain stability.</p>